New insights into clinical response in schizophrenia: from dopamine D2 receptor occupancy to patients' quality of life.

[1]  J. Lieberman,et al.  Relationship of cognition and psychopathology to functional impairment in schizophrenia. , 2008, The American journal of psychiatry.

[2]  Christoph Hiemke,et al.  Brain and plasma pharmacokinetics of aripiprazole in patients with schizophrenia: an [18F]fallypride PET study. , 2008, The American journal of psychiatry.

[3]  R. Mcquade,et al.  Differences in agonist/antagonist properties at human dopamine D(2) receptors between aripiprazole, bifeprunox and SDZ 208-912. , 2007, European journal of pharmacology.

[4]  Shitij Kapur,et al.  Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study. , 2007, The American journal of psychiatry.

[5]  S. Eack,et al.  Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis. , 2007, Schizophrenia bulletin.

[6]  Philip D. Harvey,et al.  Performance-based measures of functional skills: usefulness in clinical treatment studies. , 2007, Schizophrenia bulletin.

[7]  Robert K. Heaton,et al.  Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. , 2006, The American journal of psychiatry.

[8]  H. Katschnig,et al.  Quality of Life in Mental Disorders , 2006 .

[9]  S. Marder,et al.  Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials , 2003, Schizophrenia Research.

[10]  Gerhard Gründer,et al.  Dopamine D2 and D3 Receptor Occupancy in Normal Humans Treated with the Antipsychotic Drug Aripiprazole (OPC 14597): A Study Using Positron Emission Tomography and [11C]Raclopride , 2002, Neuropsychopharmacology.

[11]  Michael F. Green,et al.  What are the functional consequences of neurocognitive deficits in schizophrenia? , 1996, The American journal of psychiatry.

[12]  W T Carpenter,et al.  The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. , 1984, Schizophrenia bulletin.